Gilead leads rivals in race to cure hepatitis C - je.st - Gilead leads rivals in race to cure hepatitis C

Home › Gilead leads rivals in race to cure hepatitis C

Gilead leads rivals in race to cure hepatitis C

2014-03-03 10:02:11| Biotech - Topix.net

Gilead Sciences' Sovaldi can cure as many as 90 percent of hepatitis C patients in 12 to 24 weeks.

Tags: leads race cure hepatitis

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

27.11	H0599bikke8.7AH
27.11	staff
27.11	TWINS 8oz
27.11
27.11	20194
27.11	V 7
27.11	20th
27.11	Under Armour Tactical T /2
More »